An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More-Reference-Cited by-同舟云学术

An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More

Published:2019-06-19 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Vitale Massimo,Cantoni Claudia,Della Chiesa Mariella,Ferlazzo Guido,Carlomagno Simona,Pende Daniela,Falco Michela,Pessino Annamaria,Muccio Letizia,De Maria Andrea,Marcenaro Emanuela,Moretta Lorenzo,Sivori Simona

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference244 articles.

1. In search of the ‘missing self’: MHC molecules and NK cell recognition;Ljunggren;Immunol Today,1990

2. Receptors for HLA class-I molecules in human natural killer cells;Moretta;Annu Rev Immunol,1996

3. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes;Moretta;Immunol Rev,1997

4. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer;Wagtmann;Immunity,1995

5. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis;Moretta;Annu Rev Immunol,2001

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreatic ductal adenocarcinoma microenvironment: Soluble factors and cancer associated fibroblasts as modulators of NK cell functions;Immunology Letters;2024-10

2. Human NK cells and cancer;OncoImmunology;2024-07-16

3. Efficacy and safety of natural killer cells injection combined with XELOX chemotherapy in postoperative patients with stage III colorectal cancer in China: a prospective randomised controlled clinical trial study protocol;BMJ Open;2024-03

4. Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with NK cells;Journal for ImmunoTherapy of Cancer;2024-03

5. Toll-Like Receptors 7/8: A Paradigm for the Manipulation of Immunologic Reactions for Immunotherapy;Viral Immunology;2023-11-01